ZimVie (NASDAQ:ZIMV) Issues Earnings Results

ZimVie (NASDAQ:ZIMVGet Free Report) issued its quarterly earnings data on Wednesday. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.02, Zacks reports. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. ZimVie updated its FY 2025 guidance to 0.800-0.950 EPS.

ZimVie Stock Performance

ZIMV traded down $0.09 on Wednesday, reaching $13.10. The company had a trading volume of 185,894 shares, compared to its average volume of 249,131. The company has a quick ratio of 1.38, a current ratio of 1.94 and a debt-to-equity ratio of 0.57. ZimVie has a 1 year low of $12.70 and a 1 year high of $22.40. The stock has a market capitalization of $361.55 million, a PE ratio of -1.00 and a beta of 2.10. The stock has a 50-day moving average price of $13.77 and a 200-day moving average price of $14.81.

About ZimVie

(Get Free Report)

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.

See Also

Earnings History for ZimVie (NASDAQ:ZIMV)

Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.